Evidence map›Paper›PMID 31106631›Full record

ArticleRenal failure2019

Resveratrol inhibits parathyroid hormone-induced apoptosis in human aortic smooth muscle cells by upregulating sirtuin 1.

Yingjie Liu, Yiru Wu, Zongli Diao, Weikang Guo, Wenhu Liu

Open access · goldAbstract read
In one paragraph

Article in Renal failure, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yingjie Liua Department of Nephrology, Faculty of Kidney Diseases , Beijing Friendship Hospital, Capital Medical University , Beijing , PR China.
Yiru Wua Department of Nephrology, Faculty of Kidney Diseases , Beijing Friendship Hospital, Capital Medical University , Beijing , PR China.
Zongli Diaoa Department of Nephrology, Faculty of Kidney Diseases , Beijing Friendship Hospital, Capital Medical University , Beijing , PR China.
Weikang Guoa Department of Nephrology, Faculty of Kidney Diseases , Beijing Friendship Hospital, Capital Medical University , Beijing , PR China.
Wenhu Liua Department of Nephrology, Faculty of Kidney Diseases , Beijing Friendship Hospital, Capital Medical University , Beijing , PR China.
Capital Medical University · CNBeijing Friendship Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular disease is the leading cause of death in patients with chronic kidney disease, so there is an urgent need to identify therapeutic targets to control the progression of cardiovascular disease. Apoptosis of aortic smooth muscle cells can promote cardiovascular disease, but the role of parathyroid hormone (PTH) and sirtuin 1 in the pathophysiology of apoptosis is still unclear.

methodsCultured human aortic smooth muscle cells (HASMCs) were stimulated with 10

resultsWe found that PTH decreased the expression of sirtuin 1 and Bcl-2, inducing apoptosis (p<.05). Resveratrol (RES), a sirtuin 1 agonist, inhibited PTH-induced apoptosis and restored Bcl-2 expression (p<.05).

conclusionsPTH induces apoptosis in HASMCs. Resveratrol inhibits PTH-induced apoptosis in HASMCs.

Indexed as

AortaApoptosisCardiovascular DiseasesCells, CulturedDrug Evaluation, PreclinicalHumansHyperparathyroidismMuscle, Smooth, VascularMyocytes, Smooth MuscleParathyroid HormonePrimary Cell CultureProto-Oncogene Proteins c-bcl-2Renal Insufficiency, ChronicResveratrolSirtuin 1Up-RegulationBCL2 protein, humanParathyroid HormoneProto-Oncogene Proteins c-bcl-2PTH protein, humanResveratrolSIRT1 protein, humanSirtuin 1apoptosisParathyroid hormoneresveratrolsirtuin 1smooth muscle

Identifiers

PMID31106631
PMCPMC6534218
OpenAlexW2946123060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.